Test for targeted therapy in acute myeloid leukemia

An Oregon Health & Science University Cancer Institute researcher has discovered that a particular hormone is responsible for driving a cancer enzyme to cause an often deadly red blood cell cancer.

Researchers working with the cancer mutation in the JAK2 enzyme have found that the enzyme is dependent on the hormone TNF-alpha to grow and cause a red blood cell cancer called polycythemia vera, said principal investigator Thomas Bumm, M.D., Ph.D., OHSU Cancer Institute member.

This research will be presented at the American Society of Hematology annual meeting in Atlanta on Monday, Dec. 10, at 3:30 p.m.

Polycythemia vera is a disease in which there are too many red blood cells in the bone marrow and blood, causing the blood to thicken. There is no cure.

Mice with normal TNF-alpha production and the JAK2 mutation developed the red blood cell disease very quickly - within two to three weeks. The blood became very thick, and they developed severe bone marrow fibrosis, excessive fibers in the bone marrow with a decrease in healthy cells. In contrast, mice without the hormone but carrying the JAK2 mutation had normal red blood cell levels and normal bone marrow.

The hormone, TNF-alpha is known as a highly potent hormone, but until now its role in cancer has not been well understood.

"If these specific hormones are understood, then there is hope to find a new way to fight these cancer cells by attacking the specific hormones triggering the cancer cells," said Bumm, a fellow in hematology/ medical oncology, OHSU School of Medicine.

There are already drugs developed that target TNF-alpha used for patients with auto immune and inflammatory diseases such as rheumatoid arthritis. But the drugs have not been used for cancer patients. Bumm said one of the next steps will be to conduct studies on a larger mouse study and also testing these different drugs' effect on this JAK2-induced cancer.

"Maybe one of these drugs will work on the mice and is safe so that we could begin testing the drugs on patients. At this point, there is no specific treatment for polycythemia vera cancer patients. Maybe we opened a new door to understand leukemia better and to fight it at a crucial root," Bumm said.

Polycythemia vera is rare, about five in every 1 million people have it. Without treatment, about half the people who have polycythemia vera with symptoms die in less than two years.

Often, people with polycythemia vera have no symptoms for years. The earliest symptoms usually are weakness, fatigue, headache, light-headedness, shortness of breath and night sweats. Vision may be distorted, and a person may have blind spots or may see flashes of light. Bleeding from the gums and more bleeding than would be expected from small cuts are common. The skin, especially the face, may look red. A person may itch all over, particularly after bathing or showering.



(Editor compiled and published Test for targeted therapy in acute myeloid leukemia at HealthNewsTrack on December 10, 2007 sourced from Oregon Health & Science University - http://www.ohsu.edu/ohsuedu/newspub/releases/121007test.cfm)

Leukemia - recent articles and current news stories:

- Umbilical cord blood to treat leukemia
- Vaccine may cure chronic myeloid leukemia CML
- Early stem cell transplant best for acute myeloid leukemia patients
- Green tea shows promise in leukemia
- Leukemia treatment developed in Australia

Most related articles:

- Test for targeted therapy in acute myeloid leukemia
- Gleevec improves special leukemia in children - 8.7
- Understanding chronic myeloid leukemia - 8.1
- Vaccine may cure chronic myeloid leukemia CML - 6.9
- Early stem cell transplant best for acute myeloid leukemia patients - 6.3

More related articles:

- Therapy, Acute myeloid leukemia, Cancer, Polycythemia vera, Hematology, Bone marrow, Oncology, Medicine, Rheumatoid arthritis
- Understanding chronic myeloid leukemia - 21.3
- Gleevec improves special leukemia in children - 14.4
- A man defeated HIV virus through bone marrow transplant - 13.3
- Nplate bone marrow stimulator approved to treat low platelet counts - 10.7

Leukemia related articles:

- Green tea shows promise in leukemia - 4.1
- Gleevec improves special leukemia in children - 3.9
- Grape seed extract may cure leukemia - 3.7
- Hannah Jones refused heart transplant surgery - 3.6
- Chemotherapy target found for leukemia - 3.6

Leukemia article/news source:

Read more health articles from Oregon Health & Science University and health articles from USA.

Leukemia - search related terms:

Acute myeloid leukemia, Bone marrow, Cancer, Hematology, Medicine, Oncology, Polycythemia vera, Rheumatoid arthritis, Therapy,
Leukemia books,

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
2.53